-
Mashup Score: 8Wolters Kluwer Health - 2 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…
Source: lww.comCategories: Latest Headlines, RheumatologyTweet-
A single high-dose oral application of #cannabidiol does not affect pain, hyperalgesia, and allodynia in healthy volunteers during an experimental model of induced #acutepain. Learn more in the #GlobalYear2022 article in #PAIN. https://t.co/ISqoVJmPwq https://t.co/BIAgNQLCcP
-
-
Mashup Score: 2
Objective To estimate the timing of cannabidiol (CBD) treatment effect (seizure reduction and adverse events [AEs]) onset, we conducted a post hoc analysis of GWPCARE6 (NCT02544763), a randomized, p…
Source: Wiley Online LibraryCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 0EPILEPSIA - Top 10 Downloaded Articles in 2021 - 2 year(s) ago
January 2022 Top 10 Downloaded Articles in 2021 Time to onset of cannabidiol (CBD) treatment effect in Lennox–Gastaut syndrome: Analysis from two randomized controlled trials Michael Privitera, Hari Bhathal, Matthew Wong, J. Helen Cross, Elaine Wirrell, Eric D. Marsh, Maria Mazurkiewicz-Beldzinska, Vicente Villanueva, Daniel Checketts,…
Source: hosted-p0.vresp.comCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 2
“Our findings do not say this will work in patients. Our findings make a strong case for a clinical trial,” said Dr. Marsha Rosner.
Source: www.mdedge.comCategories: Latest Headlines, PsychiatryTweet
-
Mashup Score: 2EPILEPSIA - New Articles (January 1, 2022) - 2 year(s) ago
December 2021 New Articles – January 1, 2022 Featured Article Long-term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: An open-label extension trial Elizabeth A. Thiele, E. Martina Bebin, Francis Filloux, Patrick Kwan, Rachael Loftus, Farhad Sahebkar, Steven Sparagana, James…
Source: hosted-p0.vresp.comCategories: Latest Headlines, NeurologyTweet-
New open-access research from @EpilepsiaJourn: "Long-term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: An open-label extension trial" #epilepsy #epilepsyresearch #antiseizuremedication #cannabidiol #focalseizures @yesILAE https://t.co/nW7oVKp2hd https://t.co/k7iX0bzeFJ
-
-
Mashup Score: 1Long‐term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: An open‐label extension trial - 2 year(s) ago
Objective To evaluate the long-term safety and efficacy of add-on cannabidiol (CBD) in patients with seizures associated with tuberous sclerosis complex (TSC) in the open-label extension (OLE) of th…
Source: Wiley Online LibraryCategories: Latest Headlines, NeurologyTweet-
Long‐term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: An open‐label extension trial https://t.co/DXqfk1uFvy RESEARCH ARTICLE #openaccess #epilepsy #epilepsyresearch #cannabidiol #seizure #antiseizuremedications @IlaeWeb @WileyNeuro @yesILAE https://t.co/2KHP3UD7P9
-
-
Mashup Score: 0Cannabinoid Use Among Liver Transplant Recipients - 2 year(s) ago
The effect of cannabinoids on liver transplant outcomes is an area of active research. We aimed to investigate marijuana (MJ) and cannabidiol (CBD) use among liver transplant recipients at the Univer…
Source: AASLDCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 0Cannabinoid Use Among Liver Transplant Recipients - 2 year(s) ago
The effect of cannabinoids on liver transplant outcomes is an area of active research. We aimed to investigate marijuana (MJ) and cannabidiol (CBD) use among liver transplant recipients at the Univer…
Source: AASLDCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 2Cannabinoid Use Among Liver Transplant Recipients - 3 year(s) ago
The effect of cannabinoids on liver transplant outcomes is an area of active research. We aimed to investigate marijuana (MJ) and cannabidiol (CBD) use among liver transplant recipients at the Univer…
Source: AASLDCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 2Long‐term safety and efficacy of add‐on cannabidiol in patients with Lennox–Gastaut syndrome: Results of a long‐term open‐label extension trial - 3 year(s) ago
Objective Lennox–Gastaut syndrome (LGS) is an epileptic encephalopathy that is often treatment resistant. Efficacy and safety of add-on cannabidiol (CBD) to treat seizures associated with LGS was de…
Source: Wiley Online LibraryCategories: Latest Headlines, NeurologyTweet
A single high-dose oral application of #cannabidiol does not affect pain, hyperalgesia, and allodynia in healthy volunteers during an experimental model of induced #acutepain. Learn more in the #GlobalYear2022 article in #PAIN. https://t.co/2icvpz9biF https://t.co/FuhEohnF03